La Jolla Pharmaceutical Company LJPC
6.19 0.00 (+0.00%)
At closeAug 15, 2022, 4:00 PM EDT
6.19 Day range 6.22
52-week range unavailable
Analyst view
Consensus: hold
Hold
Price target (mean) 6.23
Ratings (0m) 6 6 buy · 0 hold · 0 sell
- Strong buy1
- Buy5
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 1
- 2 months ago 1
- 3 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.04 | 0.04 – 0.04 | -0.08 | +150.0% | 14.26M | +7.1% | 1 |
| Next quarter | 0.03 | 0.03 – 0.03 | 0.12 | -75.0% | 16.25M | +33.1% | 1 |
| Current year | 0.04 | 0.04 – 0.04 | 0.58 | -93.1% | 52.78M | -30.3% | 1 |
| Next year | 0.23 | 0.23 – 0.23 | 0.04 | +475.0% | 63.95M | +21.2% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 26, 2019 | H.C. Wainwright | Downgrade | Buy | Neutral |
| Nov 25, 2019 | SunTrust Robinson Humphrey | Downgrade | Buy | Hold |
| Jan 23, 2019 | JP Morgan | Upgrade | Underweight | Neutral |
| Jan 14, 2019 | Jefferies | Upgrade | Underperform | Hold |
| Aug 10, 2018 | JP Morgan | Maintained | Underweight | Underweight |
| Aug 9, 2018 | Jefferies | Maintained | Underperform | Underperform |
| Dec 21, 2017 | H.C. Wainwright | Initiated | — | Buy |
| Dec 8, 2017 | JP Morgan | Downgrade | Overweight | Underweight |
| Aug 30, 2017 | JP Morgan | Initiated | — | Overweight |
| Feb 27, 2017 | SunTrust Robinson Humphrey | Maintained | Buy | Buy |
| Jun 22, 2016 | SunTrust Robinson Humphrey | Initiated | — | Buy |
| Feb 9, 2016 | Cowen & Co. | Initiated | — | Outperform |
| Apr 21, 2015 | Oppenheimer | Initiated | — | Outperform |
| Aug 4, 2014 | Jefferies | Initiated | — | Buy |
| May 5, 2014 | H.C. Wainwright | Initiated | — | Buy |